(1H-Imidazol-2-ylmethyl)(3-methoxypropyl)amine

Catalog No.: 
ACALKX985
CAS No.: 
920450-20-0
Molecular Formula: 
C8H15N3O
Molecular Weight: 
169.23
(1H-Imidazol-2-ylmethyl)(3-methoxypropyl)amine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg95%$213.00InquiryInquiry
1g95%$632.00InquiryInquiry
5g95%$3128.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(1H-Imidazol-2-ylmethyl)(3-methoxypropyl)amine
IUPAC NameN-((1H-imidazol-2-yl)methyl)-3-methoxypropan-1-amine
MDL No.MFCD09881490
Molecular FormulaC8H15N3O
Molecular Weight169.23
SMILESCOCCCNCC1=NC=CN1
InChI KeyONGLPWUXMKZYNO-UHFFFAOYSA-N
Synonym(1H-Imidazol-2-ylmethyl)(3-methoxypropyl)amine;1H-Imidazole-2-methanamine, N-(3-methoxypropyl)-
CAS No.920450-20-0

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H315-H319
Precautionary Statement(s)
P264-P280-P302+P352-P305+P351+P338-P332+P313-P337+P313-P362

Synthetic Route by SureRoute

1. ACALKX985 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACBWAG179 route compound structure diagram
    ACBWAG17918600-41-4In Stock
  2. Plus
  3. ACYLAB428 route compound structure diagram
    ACYLAB42810111-08-7In Stock
  4. Then
  5. ACALKX985 route product structure diagram
    ACALKX985920450-20-0
Inquiry

2. ACALKX985 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACBWAG179 route compound structure diagram
    ACBWAG17918600-41-4In Stock
  2. Plus
  3. ACRAEP931 route compound structure diagram
    ACRAEP931116177-22-1
  4. Then
  5. ACALKX985 route product structure diagram
    ACALKX985920450-20-0
Inquiry

3. ACALKX985 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACALKX985 route product structure diagram
    ACALKX985920450-20-0
Inquiry

Comments (0)